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Studies described by Eisele et al. (2013) and Xavier et al. (2013) in this issue of Cell Host & Microbe show that
the bacterial pathogens Salmonella and Brucella exploit the increased levels of glucose present in
alternatively activated macrophages to sustain chronic infections in experimentally infected mice.Anyone who has ever played tennis, golf,
or baseball has an appreciation for the
phrase ‘‘finding the sweet spot.’’ When
the ball makes contact with the racket,
club, or bat in just the ‘‘right’’ place, the
ball goes where you want it to go, and
you get the maximum benefit from
this interaction. Experimental evidence
presented in this issue of Cell Host &
Microbe indicates that the bacterial
pathogens Salmonella and Brucella have
found a ‘‘sweet spot’’ in alternatively
activated macrophages and exploit this
niche to sustain chronic infections in their
mammalian hosts.
Salmonella and Brucella strains are
important pathogens in human and
veterinary medicine. Although the dis-
eases they produce in their natural and
incidental hosts are generally quite
different, both of these bacteria have
the capacity to survive and replicate for
prolonged periods in macrophages,
which allows them to establish and main-
tain chronic infections (Monack et al.,
2004; Roop et al., 2009). During progres-
sion of the host inflammatory response to
infection, macrophages can develop into
two types depending upon the cytokines
they encounter (Biswas and Mantovani,
2012). Stimulation by IFN-g leads
to the development of classically
activated macrophages (CAMs), which
attain enhanced microbicidal activity
and secrete proinflammatory cytokines.
These phagocytes play an important
role in the Th1 arm of the acquired
immune response. In contrast, stimula-
tion by IL-4 and IL-13 leads to the
development of alternatively activated
macrophages (AAMs), which have
reduced microbicidal activity and secrete
anti-inflammatory cytokines. AAMs play
critical roles in resolution of the inflam-matory response and wound healing.
One consequence of the polarization of
macrophages to the CAM- or AAM-type
is a shift in their cellular metabolism.
CAMs, for instance, rely on glycolysis
for their energy and consume significant
levels of glucose. AAMs, on the other
hand, degrade fatty acids via the
b-oxidation pathway as their source of
carbon and energy.
Employing mouse models of chronic
Salmonella and Brucella infections,
respectively, Eisele et al. (2013) and
Xavier et al. (2013) have found that
AAMs become the predominant form of
macrophages inhabited by both of these
bacteria during chronic infections. In
both cases, these investigators showed
that (1) intracellular glucose levels were
higher in the AAMs than in the CAMs;
(2) the bacteria were able to survive and
replicate more efficiently in AAMs than
in CAMs in culture and in experimentally
infected animals; and (3) in order to be
able to effectively replicate in the AAMs,
these bacteria had to be able to transport
(and presumably metabolize) glucose. In
neither study, however, did the investiga-
tors find evidence that the reduced
microbicidal activities of the AAMs were
responsible for the enhanced intracellular
replication of the Salmonella and Brucella
strains in these phagocytes. These find-
ings are important because they indicate
that it is the increased availability of
glucose as a carbon and energy source
that makes AAMs a permissive site for
intracellular replication of the salmonellae
and brucellae during chronic infections
rather than the fact that AAMs have
reduced bactericidal activities compared
to CAMs. In other words, these bacteria
have literally found a ‘‘sweet spot’’
in AAMs where they can derive theCell Host & Microbe 14maximum benefit from their interac-
tions with host macrophages and sus-
tain chronic infections in their hosts
(Figure 1).
Despite the commonalities in the inter-
actions of the Salmonella and Brucella
strains with AAMs, the individual studies
described by Eisele et al. (2013) and
Xavier et al. (2013) also found some
important differences. Signal transduc-
tion through the nuclear peroxisome pro-
liferator-activated receptors PPARg and
PPARd orchestrates the patterns of
gene expression required for the devel-
opment of AAMs (Odegaard and Chawla,
2011). Eisele et al. (2013) found that
infection of cultured macrophages with
Salmonella induces expression of the
gene encoding PPARd, but not PPARg.
Moreover, they showed that modulation
of PPARg levels in AAMs had a signifi-
cant impact on the capacity of Salmo-
nella to replicate in these phagocytes,
but did not influence the intracellular
replication of Mycobacterium, Franci-
sella, or Listeria strains within these host
cells. These experimental findings lead
the authors to hypothesize that the effect
on PPARd is unique to Salmonella and
that this bacterium plays an active role
in driving the polarization of macro-
phages toward the AAM phenotype. In
contrast, while Xavier et al. (2013) found
that PPARg is responsible for the shift
in metabolism that allows Brucella strains
to gain access to glucose and replicate
efficiently within AAMs, they could find
no evidence that infection with Brucella
strains had an impact on the develop-
ment of macrophages into either the
CAM or AAM phenotype. Clearly the
differential roles of PPARg and PPARd
in driving the development of AAMs
during the course of Salmonella and, August 14, 2013 ª2013 Elsevier Inc. 119
Figure 1. Finding the ‘‘Sweet Spot’’
A model showing how the equilibrium between the intracellular residence of
Salmonella and Brucella strains (shown in red) in alternatively activated
macrophages (AAMs) and classically activated macrophages (CAMs) and
the availability of intracellular glucose in these macrophages influences the
progression of these infections.
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further study, as does deter-
mining the extent to which
these bacteria actively partic-
ipate in this process. But
given the fact that Salmonella
strains induce a much stron-
ger inflammatory response
than Brucella strains (Bar-
quero-Calvo et al., 2007), it
would not be surprising to
find that Salmonella strains
require an active mechanism
for enhancing the availability
of AAMs in order establish
and maintain a chronic infec-
tion, while Brucella strains
do not.
In addition to improving our
basic understanding of the
mechanisms employed by
Salmonella and Brucella
strains to produce disease in
their hosts, and the different
roles that CAMs and AAMsplay in protective immunity and host-
pathogen interactions, the results of the
studies of Eisele et al. (2013) and Xavier
et al. (2013) may also have important
implications for the treatment of Salmo-
nella and Brucella infections in humans.
Although naturally occurring antibiotic
resistance in Brucella strains is rare,
brucellosis in humans is notoriously diffi-
cult to treat, requiring a combination of
antibiotics administered for at least six
weeks (Ariza et al., 2007). Antibiotic resis-
tance and the existence of a chronic
carrier state also complicate the effective120 Cell Host & Microbe 14, August 14, 2013treatment of Salmonella infections in
humans (Pegues et al., 2005). Drugs that
target PPAR activity have been proposed
for use in treating a variety of diseases
including diabetes, cardiac disease, and
inflammatory bowel disease (Mandard
and Patsouris, 2013). Consequently, the
findings presented by Eisele et al. (2013)
and Xavier et al. (2013) raise the possibility
that these drugs may also be useful alone
or in combination with antibiotics for the
treatment of two bacterial diseases that
have considerable public health impor-
tance on a global scale.ª2013 Elsevier Inc.REFERENCES
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